0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: October 2022
|
Report Code: QYRE-Auto-14J6373
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Diabetic Foot Ulcer DFU Therapeutic Market Insights Forecast to 2028
BUY CHAPTERS

Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-14J6373
Report
October 2022
Pages:113
QYResearch
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Diabetic foot ulcers are among one of the major global medical issues. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary therapeutic approach so as to avoid amputation.
Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Diabetic Foot Ulcer (DFU) Therapeutic market is projected to reach US$ 7136.3 million by 2028 from an estimated US$ 4949 million in 2022, at a CAGR of 6.3% during 2023 and 2028.

Global main players in the diabetic foot ulcer (DFU) therapeutic industry are 3M, Smith & Nephew, Molnlycke Health Care, account for about a third of market share in total. Geographically speaking, North America is the largest market, accounting for about 40% of total market share, followed by Europe with a share of over 30%. In terms of type, wound care dressing segment holds an important share of over 50%. In terms of application, neuro-ischemic ulcers holds about 50% share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Diabetic Foot Ulcer (DFU) Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Diabetic Foot Ulcer (DFU) Therapeutic.
The Diabetic Foot Ulcer (DFU) Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Diabetic Foot Ulcer (DFU) Therapeutic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Foot Ulcer (DFU) Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
3M
Smith & Nephew
Molnlycke Health Care
ConvaTec
Coloplast
Integra LifeSciences
Essity (BSN Medical)
Medline
B. Braun
Organogenesis
Product Type Insights
Global markets are presented by Diabetic Foot Ulcer (DFU) Therapeutic type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Diabetic Foot Ulcer (DFU) Therapeutic are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Diabetic Foot Ulcer (DFU) Therapeutic Segment by Type

Wound Care Dressing
Biologics
Therapy Devices
Antibiotic Medications
Others
Application Insights
This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Diabetic Foot Ulcer (DFU) Therapeutic market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Diabetic Foot Ulcer (DFU) Therapeutic market.

Diabetic Foot Ulcer (DFU) Therapeutic Segment by Application

Neuropathic Ulcers
Ischemic Ulcers
Neuro-ischemic Ulcers
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Diabetic Foot Ulcer (DFU) Therapeutic market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Foot Ulcer (DFU) Therapeutic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Diabetic Foot Ulcer (DFU) Therapeutic and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Diabetic Foot Ulcer (DFU) Therapeutic industry.
This report helps stakeholders to gain insights into which regions to target globally.
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Foot Ulcer (DFU) Therapeutic.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

1 Study Coverage
1.1 Diabetic Foot Ulcer (DFU) Therapeutic Product Introduction
1.2 Market by Type
1.2.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Wound Care Dressing
1.2.3 Biologics
1.2.4 Therapy Devices
1.2.5 Antibiotic Medications
1.2.6 Others
1.3 Market by Application
1.3.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Neuropathic Ulcers
1.3.3 Ischemic Ulcers
1.3.4 Neuro-ischemic Ulcers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Estimates and Forecasts
2.2 Diabetic Foot Ulcer (DFU) Therapeutic Market Size by Region: 2022 Versus 2028
2.2.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region: 2017-2022
2.2.2 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Region (2023-2028)
2.2.3 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Region (2017-2028)
3 Global Diabetic Foot Ulcer (DFU) Therapeutic by Company
3.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Company (2017-2022)
3.2 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Diabetic Foot Ulcer (DFU) Therapeutic Companies around the World: Ranking by Revenue
3.3.2 Global Diabetic Foot Ulcer (DFU) Therapeutic Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Diabetic Foot Ulcer (DFU) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Headquarters & Product Type
3.4.1 Diabetic Foot Ulcer (DFU) Therapeutic Companies Headquarters
3.4.2 Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Product & Service
3.4.3 Date of International Companies Enter into Diabetic Foot Ulcer (DFU) Therapeutic Market
3.5 Global Diabetic Foot Ulcer (DFU) Therapeutic Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 3M
4.1.1 3M Corporation Information
4.1.2 3M Description, Business Overview
4.1.3 3M Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.1.4 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.1.5 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.1.6 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.1.7 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.1.8 3M Recent Developments
4.2 Smith & Nephew
4.2.1 Smith & Nephew Corporation Information
4.2.2 Smith & Nephew Description, Business Overview
4.2.3 Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.2.4 Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.2.5 Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.2.6 Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.2.7 Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.2.8 Smith & Nephew Recent Developments
4.3 Molnlycke Health Care
4.3.1 Molnlycke Health Care Corporation Information
4.3.2 Molnlycke Health Care Description, Business Overview
4.3.3 Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.3.4 Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.3.5 Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.3.6 Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.3.7 Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.3.8 Molnlycke Health Care Recent Developments
4.4 ConvaTec
4.4.1 ConvaTec Corporation Information
4.4.2 ConvaTec Description, Business Overview
4.4.3 ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.4.4 ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.4.5 ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.4.6 ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.4.7 ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.4.8 ConvaTec Recent Developments
4.5 Coloplast
4.5.1 Coloplast Corporation Information
4.5.2 Coloplast Description, Business Overview
4.5.3 Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.5.4 Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.5.5 Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.5.6 Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.5.7 Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.5.8 Coloplast Recent Developments
4.6 Integra LifeSciences
4.6.1 Integra LifeSciences Corporation Information
4.6.2 Integra LifeSciences Description, Business Overview
4.6.3 Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.6.4 Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.6.5 Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.6.6 Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.6.7 Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.6.8 Integra LifeSciences Recent Development
4.7 Essity (BSN Medical)
4.7.1 Essity (BSN Medical) Corporation Information
4.7.2 Essity (BSN Medical) Description, Business Overview
4.7.3 Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.7.4 Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.7.5 Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.7.6 Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.7.7 Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.7.8 Essity (BSN Medical) Recent Development
4.8 Medline
4.8.1 Medline Corporation Information
4.8.2 Medline Description, Business Overview
4.8.3 Medline Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.8.4 Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.8.5 Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.8.6 Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.8.7 Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.8.8 Medline Recent Development
4.9 B. Braun
4.9.1 B. Braun Corporation Information
4.9.2 B. Braun Description, Business Overview
4.9.3 B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.9.4 B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.9.5 B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.9.6 B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.9.7 B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.9.8 B. Braun Recent Development
4.10 Organogenesis
4.10.1 Organogenesis Corporation Information
4.10.2 Organogenesis Description, Business Overview
4.10.3 Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Products Offered
4.10.4 Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue and Gross Margin (2017-2022)
4.10.5 Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Product in 2021
4.10.6 Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application in 2021
4.10.7 Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Geographic Area in 2021
4.10.8 Organogenesis Recent Development
5 Breakdown Data by Type
5.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022)
5.2 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Type (2023-2028)
5.3 Diabetic Foot Ulcer (DFU) Therapeutic Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022)
6.2 Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Application (2023-2028)
6.3 Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Diabetic Foot Ulcer (DFU) Therapeutic Market Size YoY Growth 2017-2028
7.2 North America Diabetic Foot Ulcer (DFU) Therapeutic Market Facts & Figures by Country (2017-2028)
7.3 North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022)
7.4 North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022)
8.4 Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022)
9 Europe
9.1 Europe Diabetic Foot Ulcer (DFU) Therapeutic Market Size YoY Growth 2017-2028
9.2 Europe Diabetic Foot Ulcer (DFU) Therapeutic Market Facts & Figures by Country (2017-2028)
9.3 Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022)
9.4 Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Diabetic Foot Ulcer (DFU) Therapeutic Market Size YoY Growth 2017-2028
10.2 Latin America Diabetic Foot Ulcer (DFU) Therapeutic Market Facts & Figures by Country (2017-2028)
10.3 Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022)
10.4 Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022)
11.4 Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Diabetic Foot Ulcer (DFU) Therapeutic Supply Chain Analysis
12.2 Diabetic Foot Ulcer (DFU) Therapeutic Key Raw Materials and Upstream Suppliers
12.3 Diabetic Foot Ulcer (DFU) Therapeutic Clients Analysis
12.4 Diabetic Foot Ulcer (DFU) Therapeutic Sales Channel and Sales Model Analysis
12.4.1 Diabetic Foot Ulcer (DFU) Therapeutic Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Diabetic Foot Ulcer (DFU) Therapeutic Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Diabetic Foot Ulcer (DFU) Therapeutic Distributors
13 Market Dynamics
13.1 Diabetic Foot Ulcer (DFU) Therapeutic Industry Trends
13.2 Diabetic Foot Ulcer (DFU) Therapeutic Market Drivers
13.3 Diabetic Foot Ulcer (DFU) Therapeutic Market Challenges
13.4 Diabetic Foot Ulcer (DFU) Therapeutic Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Companies of Wound Care Dressing
    Table 3. Major Companies of Biologics
    Table 4. Major Companies of Therapy Devices
    Table 5. Major Companies of Antibiotic Medications
    Table 6. Major Companies of Others
    Table 7. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size by Region (US$ Million): 2022 VS 2028
    Table 9. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 11. Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Company (2017-2022) & (US$ Million)
    Table 12. Diabetic Foot Ulcer (DFU) Therapeutic Revenue Share by Company (2017-2022)
    Table 13. Ranking of Global Top Diabetic Foot Ulcer (DFU) Therapeutic Players by Revenue (US$ Million) in 2021
    Table 14. Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 15. Global Diabetic Foot Ulcer (DFU) Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetic Foot Ulcer (DFU) Therapeutic as of 2021)
    Table 16. Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Headquarters
    Table 17. Global Diabetic Foot Ulcer (DFU) Therapeutic Companies Product & Service
    Table 18. Date of International Companies Enter into Diabetic Foot Ulcer (DFU) Therapeutic Market
    Table 19. Global Diabetic Foot Ulcer (DFU) Therapeutic Mergers & Acquisitions, Expansion Plans
    Table 20. 3M Corporation Information
    Table 21. 3M Description and Business Overview
    Table 22. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 23. 3M Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 24. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 25. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 26. 3M Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 27. 3M Recent Development
    Table 28. Smith & Nephew Corporation Information
    Table 29. Smith & Nephew Description and Business Overview
    Table 30. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 31. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 32. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 33. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 34. Smith & Nephew Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 35. Smith & Nephew Recent Development
    Table 36. Molnlycke Health Care Corporation Information
    Table 37. Molnlycke Health Care Description and Business Overview
    Table 38. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 39. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 40. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 41. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 42. Molnlycke Health Care Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 43. Molnlycke Health Care Recent Development
    Table 44. ConvaTec Corporation Information
    Table 45. ConvaTec Description and Business Overview
    Table 46. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 47. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 48. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 49. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 50. ConvaTec Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 51. ConvaTec Recent Development
    Table 52. Coloplast Corporation Information
    Table 53. Coloplast Description and Business Overview
    Table 54. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 55. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 56. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 57. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 58. Coloplast Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 59. Coloplast Recent Development
    Table 60. Integra LifeSciences Corporation Information
    Table 61. Integra LifeSciences Description and Business Overview
    Table 62. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 63. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 64. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 65. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 66. Integra LifeSciences Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 67. Essity (BSN Medical) Corporation Information
    Table 68. Essity (BSN Medical) Description and Business Overview
    Table 69. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 70. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 71. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 72. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 73. Essity (BSN Medical) Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 74. Medline Corporation Information
    Table 75. Medline Description and Business Overview
    Table 76. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 77. Medline Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 78. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 79. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 80. Medline Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 81. B. Braun Corporation Information
    Table 82. B. Braun Description and Business Overview
    Table 83. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 84. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 85. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 86. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 87. B. Braun Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 88. Organogenesis Corporation Information
    Table 89. Organogenesis Description and Business Overview
    Table 90. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue (US$ Million) and Gross Margin (2017-2022)
    Table 91. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Product
    Table 92. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Product in 2021
    Table 93. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Application in 2021
    Table 94. Organogenesis Diabetic Foot Ulcer (DFU) Therapeutic Revenue Proportion of Diabetic Foot Ulcer (DFU) Therapeutic by Geographic Area in 2021
    Table 95. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
    Table 97. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 98. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
    Table 99. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
    Table 100. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
    Table 101. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region (2017-2028) & (US$ Million)
    Table 103. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Region (2023-2028) & (US$ Million)
    Table 104. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
    Table 105. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
    Table 106. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
    Table 109. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
    Table 110. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
    Table 111. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
    Table 112. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
    Table 113. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
    Table 114. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2017-2022) & (US$ Million)
    Table 115. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Country (2023-2028) & (US$ Million)
    Table 116. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Type (2017-2022) & (US$ Million)
    Table 117. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue by Application (2017-2022) & (US$ Million)
    Table 118. Diabetic Foot Ulcer (DFU) Therapeutic Key Raw Materials, Industry Status and Trend
    Table 119. Diabetic Foot Ulcer (DFU) Therapeutic Key Raw Materials and Upstream Suppliers
    Table 120. Diabetic Foot Ulcer (DFU) Therapeutic Clients Status and Trend
    Table 121. Diabetic Foot Ulcer (DFU) Therapeutic Typical Clients
    Table 122. Diabetic Foot Ulcer (DFU) Therapeutic Distributors
    Table 123. Diabetic Foot Ulcer (DFU) Therapeutic Market Trends
    Table 124. Diabetic Foot Ulcer (DFU) Therapeutic Market Drivers
    Table 125. Diabetic Foot Ulcer (DFU) Therapeutic Market Challenges
    Table 126. Diabetic Foot Ulcer (DFU) Therapeutic Market Restraints
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Diabetic Foot Ulcer (DFU) Therapeutic Product Picture
    Figure 2. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type in 2021 & 2028
    Figure 3. Wound Care Dressing Product Picture
    Figure 4. Biologics Product Picture
    Figure 5. Therapy Devices Product Picture
    Figure 6. Antibiotic Medications Product Picture
    Figure 7. Others Product Picture
    Figure 8. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application in 2021 & 2028
    Figure 9. Neuropathic Ulcers
    Figure 10. Ischemic Ulcers
    Figure 11. Neuro-ischemic Ulcers
    Figure 12. Diabetic Foot Ulcer (DFU) Therapeutic Report Years Considered
    Figure 13. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size 2017-2028 (US$ Million)
    Figure 15. Global Diabetic Foot Ulcer (DFU) Therapeutic Market Size Market Share by Region: 2022 Versus 2028
    Figure 16. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Region (2017-2028)
    Figure 17. Diabetic Foot Ulcer (DFU) Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share Forecast by Type (2017-2028)
    Figure 19. Global Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share Forecast by Application (2017-2028)
    Figure 20. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue 2017-2028 (US$ Million)
    Figure 21. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
    Figure 22. North America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
    Figure 23. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue 2017-2028 (US$ Million)
    Figure 24. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Region (2017-2028)
    Figure 25. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
    Figure 26. Asia-Pacific Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
    Figure 27. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 28. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Country (2017-2028)
    Figure 29. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
    Figure 30. Europe Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
    Figure 31. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 32. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Country (2017-2022)
    Figure 33. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
    Figure 34. Latin America Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
    Figure 35. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 36. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Country (2017-2028)
    Figure 37. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Type (2017-2022)
    Figure 38. Middle East and Africa Diabetic Foot Ulcer (DFU) Therapeutic Revenue Market Share by Application (2017-2022)
    Figure 39. Diabetic Foot Ulcer (DFU) Therapeutic Supply Chain (Upstream and Downstream Market)
    Figure 40. Global Production Market Share of Diabetic Foot Ulcer (DFU) Therapeutic Raw Materials by Region in 2021
    Figure 41. Diabetic Foot Ulcer (DFU) Therapeutic Distribution Channels
    Figure 42. Global Diabetic Foot Ulcer (DFU) Therapeutic Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 43. Global Diabetic Foot Ulcer (DFU) Therapeutic Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 44. Bottom-up and Top-down Approaches for This Report
    Figure 45. Data Triangulation
    Figure 46. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS